Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

City View Multicare Center, 5825 W Cermak Rd, Cicero, IL 60804, USA

Total all time reports:  1
Latest report: April 28, 2020 12:00 PM
Residents and staff at Cicero nursing home test positive for COVID-19, City View Multicare Center, 5825 W Cermak Rd, Cicero, IL 60804, USA

Residents and staff at Cicero nursing home test positive for COVID-19

April 28, 2020 12:00 PM

“Cicero officials announced that at least 163 residents at City View Multi-Care Center had tested positive for COVID-19, In addition, 41 workers have tested positive.


Source: chicagotribune.com See Less
Reported By SafelyHQ.com User

Related Reports

July 10, 2020 4:21 PM

“The company has had a worker test positive for covid-19 after being around other workers and letting the worker return back without retesting! The company won’t send any other workers to get tested because they don’t wanna pay or lose money, risking everyones health! The company is sorry and selfles ... See Mores! See Less
Reported By SafelyHQ.com User

July 9, 2020 12:10 PM

“I work at old navy and I have to tell security everyday to put on their mask. They never wear their mask like ever. I do believe they lied about having the right filtration system just so they can open See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Coolidge Unified School District, 450 N Arizona Blvd, Coolidge, AZ 85128, USA

Coolidge Unified School District, 450 N Arizona Blvd, Coolidge, AZ 85128, USA

July 9, 2020 12:00 PM

“A Coolidge Unified School District employee working at the meal distribution program tested positive for COVID-19. The program will be closed until Aug 10.

Source: pinalcentral.com See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“A second employee at Fat Head's Brewery
Beer Hall in Middleburg Heights tested positive for COVID-19 on July 7

Source: fox8.com See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“Two additional individuals that have tested positive for Covid-19 reported being at the Fifth Avenue bar in Royal Oak, one on Saturday, June 20, and the other on Saturday, June 27. The new cases come a week after three people reported testing positive for the coronavirus after visiting the bar on th ... See Moree evening of Friday, June 19

Source: freep.com
See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“Not feeling good, have some of the symptoms, scared to test, will behave as if I have covid-19 and take care of myself See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“A Matson dock worker in Honolulu tested positive for COVID-19 on July 6.

Source: khon2.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, MGM National Harbor, 101 MGM National Ave, Oxon Hill, MD 20745, USA

MGM National Harbor, 101 MGM National Ave, Oxon Hill, MD 20745, USA

July 9, 2020 12:00 PM

“A dealer at the MGM National Harbor in Oxon Hill has tested positive for COVID-19.

Source: nbcwashington.com See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“Five more employees at Chumash Casino Resort have tested positive for COVID-19. One is a custodian that last worked on June 21 and another worked Friday, June 19 through Monday, June 22.

Source: keyt.com See Less
Reported By SafelyHQ.com User

July 9, 2020 12:00 PM

“I live with my aunt and uncle. both of them tested positive for covid-19. i still don’t have any symptoms. i’m just waiting for it to hit me at this point. See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 6, 2020 4:00 PM

“Company name: Baxter International Inc.
Brand name: Granules
Product recalled: Metformin Hydrochloride Extended-Release Tablets USP, 750 mg
Reason of the recall: N-Nitrosodimethylamine (NDMA)
FDA Recall date: July 06, 2020
Recall details: Company Announcement Granules Pharmaceuticals, Inc., Cha ... See Morentilly, VA is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of NNitrosodimethylamine (NDMA) levels above the Acceptable Daily Intake Limit. Granules’ test results showed NDMA levels above the FDA acceptable limit in one (1) out of the twelve (12) batches distributed to the US market. All other batches continue to remain within the specifications. Out of abundance of caution Granules Pharmaceuticals, Inc. has decided to voluntarily recall all twelve (12) of the distributed lots within expiry of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg from the market. Granules Pharmaceuticals, Inc. has not received any reports of adverse events that have been confirmed to be directly related to this recall as of the date of this letter. Granules Metformin Hydrochloride Immediate-Release Tablets USP, 500 mg, 850 mg & 1000 mg and Metformin Hydrochloride Extended-Release Tablets USP, 500 mg are not affected by this recall. Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables. Metformin Hydrochloride Extended-Release Tablets USP, 750 mg are indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. The Metformin Hydrochloride Extended-Release Tablets USP, 750 mg lots subject to the recall is identified in the table below. Metformin Hydrochloride Extended-Release Tablets USP, 750 mg
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

July 7, 2020 4:35 PM

“you guys sold me undercooked chicken See Less
Reported By SafelyHQ.com User

April 20, 2020 6:00 PM

“Company name: Braun Medical Inc
Brand name: B. Braun
Product recalled: Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container
Reason of the recall: Out-of-Specification Results for High Molecular Weight Polymers
FDA Recall date: April 20, 2020
Recall de ... See Moretails: Braun Medical Inc. (B. Braun) is voluntarily recalling one (1) lot of 2g Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container to the hospital/user level.. During stability testing of Batch H8J812, test results were found to exceed the specification limits for High Molecular Weight Polymers (HMWP) at the nineteen (19) month [82 week] stability interval. Elevated levels of High Molecular Weight Polymers have been shown to cause kidney damage and liver issues in animal studies. While the impact of HMWP in humans is unknown, B. Braun is initiating this voluntary recall out of an abundance of caution to prevent any risks of adverse reactions due to the elevated HMWP levels.

To date there have been no complaints or reports of adverse reactions associated with this product lot. Ceftazidime for Injection USP and Dextrose Injection USP is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible isolates of the designated microorganisms: Lower respiratory tract infections; skin and skin-structure infections; bacterial septicemia; bone and joint infections; gynecologic infections; intra-abdominal infections; and central nervous system infections.

Ceftazidime for Injection USP and Dextrose Injection USP in the DUPLEX® Container is a flexible dual chamber container containing approximately 50 mL of 5% Dextrose Injection in the diluent chamber and ceftazidime in the drug powder chamber. After reconstitution, the concentration is equivalent to 2 g ceftazidime. Ceftazidime for Injection USP and Dextrose Injection USP is packaged in 24 DUPLEX® Containers per case. The affected recalled product includes the following lot number and expiration date:

- NDC: 0264-3145-11. Ref: 3145-11. Dose/Volume: 2 g per 50 mL. Impacted batch: H8J812. Exp. Date: 31 Jul 2020.

Product was distributed Nationwide within the United States to domestic distributors. Pictures of the product and product labeling follow this press release.

B. Braun is notifying its distributors and customers by an official recall notice sent via certified registered mail and is arranging for return of all recalled products. Facilities and distributors that have product which is being recalled should discontinue use immediately and contact the B. Braun Medical Inc. Customer Support Department

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

Flat out raw chicken, Arby's, 14020 23 Mile Road, Shelby, MI 48315, USA

Arby's, 14020 23 Mile Road, Shelby, MI 48315, USA

June 2, 2020 9:35 PM

“they sold me flat out raw chicken , the staff is a bunch of kids who do not care always out side talking to friends and playing with there cars See Less
Reported By SafelyHQ.com User

March 15, 2020 4:11 PM

“I walked by Bar PIsellino at 5:21 PM on Sat, March 14 and it was packed inside the restaurant and also in the outdoor seating area. I have a picture. They are clearly not following the requirement to reduce capacity by 50% to help reduce the spread of coronavirus. This is extremely socially irrespo ... See Morensible! See Less
Reported By SafelyHQ.com User

Austin Texas protests, 368-398 West Cesar Chavez Street, Austin, TX, USA

368-398 West Cesar Chavez Street, Austin, TX, USA

June 3, 2020 4:59 PM

“This was jun 1st. It appeared there was some kind of military on the rooftop watching. See Less
Reported By SafelyHQ.com User

June 1, 2020 6:00 PM

“Company name: Amneal Pharmaceuticals LLC
Brand name: Amneal
Product recalled: Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
Reason of the recall: Due to detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 01, 2020
Recall details: Amneal Pharmaceuticals L ... See MoreLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, showed N-Nitrosodimethylamine (NDMA) amounts above acceptable FDA levels.

FDA recommended the recall of the seven tested lots. Amneal has agreed to this recall and has further decided to extend the recall to all lots within expiry of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, out of an abundance of caution. Further scientific evaluations are ongoing at Amneal. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall. Amneal’s Metformin Hydrochloride Immediate Release Tablets, USP are not affected by this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products, and vegetables. Metformin HCl Extended-Release Tablets, USP, 500 mg and 750 mg, manufactured by Amneal, are prescription, solid oral products that are indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. The Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, subject to the recall, are identified by the NDC numbers stated on the product label.

Metformin HCl Extended-Release Tablets, USP, 500 mg
53746-178-01. 100 count bottles
53746-178-05. 500 count bottles
53746-178-10. 1000 count bottles
53746-178-90. 90 count bottles
53746-178-Bulk. Bulk Box
65162-178-09. 90 count bottles
65162-178-10. 100 count bottles
65162-178-11. 1000 count bottles
65162-178-50. 500 count bottles

Metformin HCl Extended-Release Tablets, USP, 750 mg
53746-179-01. 1000 count bottles
53746-179-Bulk. Bulk Box
65162-179-10. 100 count bottles

The affected Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, lots were distributed nationwide in the US directly to Wholesalers, Distributors, Retailers, and Repackagers.

Amneal is notifying its direct customers via mail (UPS Standard Overnight) by mailing a recall notification letter and is arranging for the return of all the recalled products. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 25, 2020 8:31 PM

“Building management informed us that someone was confirmed tested positive in our building. See Less
Reported By SafelyHQ.com User

March 25, 2020 12:41 PM

“The company’s Soho location closed earlier this week. The employee who tested positive for COVID-19 was last in the Soho store on Tuesday, March 17, according to a company spokesperson. It’s still up-in-the-air when the Soho Trader Joe’s will reopen, but standard protocol is to close at least three ... See Moredays for cleaning.

“Out of an abundance of caution, we have temporarily closed the store for thorough cleaning and sanitization. As soon as the store has been fully cleaned and restocked, we plan to reopen,” Trader Joe’s said in an announcement on their website.
Source: ny.eater.com
See Less
Reported By SafelyHQ.com User

March 30, 2020 4:04 PM

“This dealerships General Manager, is NOT complying with our City’s mandated Stay Home order. According to manager, dealership is Essential and he already has a sales schedule set out for March 31, 2020 - end of April 2020. This is ridiculous. This type of behavior shows ZERO REGARD for the safety o ... See Moref himself, his family, his employees or their families, including the City of Fresno. This needs to be shut down and definitely reprimanded for actions. See Less
Reported By SafelyHQ.com User